Lipid peroxidation in type 2 normolipidemic diabetic patients

Diabetes Research and Clinical Practice

Volumn 36, Issue 2, 1997, Pages 71-75

  Freitas, J P ^a   Filipe, P M ^a   Guerra Rodrigo, F ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Cholesterol; Free radicals; Glycation; Lipid peroxidation; Malondialdehyde; Thiobarbituric acid reactive substances; Triglyceride; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; FRUCTOSAMINE; GLUCOSE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; NITROBLUE TETRAZOLIUM; POLYUNSATURATED FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; COLORIMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; FATTY ACID OXIDATION; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS;

AGED; AGED, 80 AND OVER; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; FREE RADICALS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES;

EID: 0030836654     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00032-6     Document Type: Article

References (45)

1. M. Brownlee, Glycation and diabetic complications, Diabetes 43 (1994) 836-841.
2. M. Brownlee, A. Cerami, H. Vlassara, Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease, Diabetes Metab. Rev. 4 (1988) 437-445.
3. M. Brownlee, H. Vlassara, A. Cerami, Nonenzymatic glycosylation and the pathogenesis of diabetic complications, Ann. Intern. Med. 101 (1984) 527-537.
4. Y. Aoki, K. Yazaki, K. Shirotori, et al., Stiffening of connective tissue in elderly diabetic patients: Relevance to diabetic nephropathy and oxidative stress, Diabetologia 36 (1993) 79-83.
5. D. Armstrong, N. Abdella, A. Salman, N. Miller, E.A. Rahman, M. Bojancyzk, Relationship of lipid peroxides to diabetic complications. Comparison with controversial laboratory tests, J. Diab. Comp. 6 (1992) 116-122.
6. J.P. Freitas, P. Filipe, J. Silva, E. Vendrell, F. Guerra-Rodrigo, Glycemic control and skin and lens advanced glycation end products in type 2 diabetes, Horm. Metab. Res. (Suppl. 1) (1995) 63.
7. L. Kennedy, J.W. Baynes, Non-enzimatic glycosylation and the chronic complications of diabetes: An overview, Diabetologia 26 (1984) 93-98.
8. E. Velazquez, P.H. Winocour, P. Kesteven, K.G. Alberti, M.F. Laker, Relation of lipide peroxides to macrovascular disease in type 2 diabetes, Diabet. Med. 8 (1991) 752-758.
9. G. Gallou, A. Ruelland, L. Campion, D. Maugendre, N. Le Moullec, B. Legras, H. Allanic, L. Cloarec, Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus, Diabetes Metabol. 20 (1994) 258-264.
10. C.J. Mullarkey, D. Edelstein, M. Brownlee, Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes, Biochem. Biophys. Res. Commun. 173 (1990) 932-939.
11. J. Emerit, D. Bonnefont, Gallia, Rôle de la peroxydation lipidique dans la constitution de la plaque d'athérome, Presse Méd. 18 (1989) 832-836.
12. G. Luc, J-C Fruchart, Oxidation of lipoproteins and atherosclerosis, Am. J. Clin. Nutr. 53 (1991) 2065-2095.
13. S. Yla-Hertuala, W Palinski, M.E. Rosenfeld, Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man, J. Clin. Invest. 84 (1989) 1086-1095.
14. M.E. Haberland, D. Fong, L. Cheng, Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits, Science 241 (1988) 215-218.
15. U.P. Steinbrecher, H. Zhang, M. Lougheed, Role of oxidatively modified LDL in atherosclerosis, Free Radical Biol. Med. 9 (1990) 155-168.
16. P. Gillery, J.C. Monboisse, F.X. Maquart, J.P. Borel, Does oxygen free radical increased formation explain long term complications of diabetes mellitus?, Med. Hypothesis 29 (1989) 47-50.
17. M. Azevedo, J. Falcão, J. Raposo, C. Manso, Superoxide radical generation by Amadori compounds, Free Radical Res. Commun. 4 (1988) 331-335.
18. A. Collier, R. Wilson, H. Bradley, J.A. Thomson, M. Small, Free radical activity in type 2 diabetes, Diabetic Med. 7 (1990) 27-30.
19. P.E. Jennings, A.F. Jones, C.M. Florkowski, J. Lunec, A.H. Barnett, Increased diene conjugates in diabetic subjects with microangiopathy, Diabetic Med. 4 (1987) 452-456.
20. E. Altomare, G. Vendemiace, D. Chicco, V. Procacci, F. Cirelli, Increased lipid peroxidation in type 2 poorly controlled diabetic patients, Diabetes Metab. 18 (1992) 264-271.
21. P. Faure, P. Corticelli, M.J. Richard, et al., Lipid peroxidation and trace element status in diabetic ketotic patients: Influence of insulin therapy, Clin. Chem. 39 (1993) 789-793.
22. Y. Sato, N. Hotta, N. Sakamoto, S. Matsuoka, N. Ohishi, K. Yagi, Lipid peroxide level in plasma of diabetic patients, Biochem. Med. 21 (1979) 104-107.
23. S. Nacitarhan, T. Ozben, N. Tuncer, Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia, Free Radical Biol. Med. 19 (1995) 893-896.
24. K. Yagi, A simple fluorimetric assay for lipoperoxide in blood plasma, Biochem. Med. 15 (1976) 212-216.
25. R.N. Johnson, P.A. Metcalf, J.R. Baker, Fructosamine: A new approach to the estimation of serum glycosylprotein. An index of diabetic control, Clin. Chem. Acta 127 (1982) 87-95.
26. J.R. Baker, J.P. O'Connor, P.A. Metcalf, M.R. Lawson, R.N. Johnson, Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus, Br. Med. J. 287 (1983) 863-867.
27. J.W. Baynes, Role of metal-catalized autoxidation in Maillard damage to proteins in vivo, Redox Rep. 1 (1994) 31-35.
28. C. Smith, M.J. Mitchinson, O.I. Aruoma, B. Halliwell, Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions, Biochem. J. 286 (1992) 901-905.
29. C.E. Thomas, R.L. Jackson, Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins, J. Pharmacol. Exp. Ther. 256 (1991) 1182-1188.
30. A.C. Fernandes, P.M. Filipe, J.P. Freitas, C.F. Manso, Different effects of thiol and nonthiol ACE inhibitors on copper-induced lipid and protein oxidative modification, Free Radical Biol. Med. 20 (1996) 507-514.
31. J.V. Hunt, R.T. Dean, S.P. Wolff, Hydroxyl radical production and autoxidative glycosylation, Biochem. J. 256 (1988) 205-212.
32. M.-X. Fu, K.J. Wells-Knecht, J.A. Blackledge, T.J. Lyons, S.R. Thorpe, J.W. Baynes, Glycation, glycoxidation, and cross-linking of collagen by glucose, Diabetes 43 (1994) 676-683.
33. M. Kitohara, H.S. Eyre, E.R. Lynch, M.L. Rollison, H.R. Hill, Metabolic activity of diabetic monocytes, Diabetes 29 (1980) 251-253.
34. S.A. Wohaieb, D. V Godin, Alterations in free radical tissue-defense mechanism in streptozotocin-induced diabetes in rat, Diabetes 36 (1987) 1014-1018.
35. J.B. Smith, C.M. Ingerman, M.J. Silver, Malondialdehyde formation as an indicator of prostaglandin production by human platelets, J. Clin. Med. 88 (1976) 167-172.
36. J.C. Doussi, M. Trouilh, M.J. Foglietti, Plasma malondialdehyde levels during myocardial infarction, Clin. Chem. Acta 129 (1983) 319-322.
37. Y. Goto, Lipid peroxides as a cause of vascular disease, in: K. Yagi, (Ed.), Lipid Peroxides in Biology and Medicine, Academic Press, New York, 1982, pp. 295-303.
38. J. Jos, M. Rybak, P.H. Patin, J.J. Robert, C. Boitard, R. Thevenin, Etude des enzymes anti-oxydantes dans le diabète insulino-dépendant de l'enfant et de l'adolescent, Diabete Métabol. 16 (1990) 498-503.
39. B. Frei, R. Stocker, B.N. Ames, Antioxidant defenses and lipid peroxidation in human blood plasma, Proc. Natl. Acad. Sci. USA 85 (1988) 9748-9752.
40. H. Sies, Strategies of antioxidant defense, Eur. J. Biochem. 215 (1993) 213-219.
41. J. McCord, Oxygen derived free radicals in post ischemic tissue injury, New Engl. J. Med. 312 (1985) 159-163.
42. D. Ganger, M. Hollwarth, D. Parks, Ischemia-reperfusion injury: Role of oxygen derived free radicals, Acta Physiol. Scand. 126 (1986) 47-63.
43. D.E. Mc Millan, The microcirculation: Changes in diabetes mellitus, Mayo Clin. Proc. 63 (1988) 517-520.
44. J.W. Baynes, Role of oxidative sress in development of complications in diabetes, Diabetes 40 (1991) 405-412.
45. J.P. Freitas, J.N. Silva, P.M. Filipe, F. Guerra Rodrigo, Lipid peroxidation and SOD activity in diabetes, in: J.T. Kumpulainen, J.T. Salonen, (Eds.), Natural Antioxidants and Food Quality in Atherosclerosis and Cancer prevention, Royal Society of Chemistry, Cambridge, UK, pp. 27-30.